| 684 |
Psychosocial Support to People affected by TB |
07/06/2024 |
TB Comorbidities and special conditions |
| 715 |
TB-HIV Bidirectional Screening |
07/06/2024 |
TB Comorbidities and special conditions |
| 716 |
TB-Diabetes Bidirectional Screening |
07/06/2024 |
TB Comorbidities and special conditions |
| 717 |
TB-Tobacco Bidirectional Screening |
07/06/2024 |
TB Comorbidities and special conditions |
| 718 |
TB-COVID Bidirectional Screening |
07/06/2024 |
TB Comorbidities and special conditions |
| 727 |
Diagnostic Algorithm for EPTB |
07/06/2024 |
TB Comorbidities and special conditions |
| 728 |
Diagnostic Algorithm for Pediatric TB |
07/06/2024 |
TB Comorbidities and special conditions |
| 747 |
Management of EPTB |
07/06/2024 |
TB Comorbidities and special conditions |
| 3197 |
Link ART Centre |
07/06/2024 |
TB Comorbidities and special conditions |
| 3198 |
ART Centre of Excellence |
07/06/2024 |
TB Comorbidities and special conditions |
| 3199 |
PMDT Treatment Book |
07/06/2024 |
TB Comorbidities and special conditions |
| 3200 |
TB Comorbidity Committee |
07/06/2024 |
TB Comorbidities and special conditions |
| 3201 |
District TB-comorbidity Coordination Committees [DTCC] |
07/06/2024 |
TB Comorbidities and special conditions |
| 3204 |
National TB-HIV Collaborative Framework |
07/06/2024 |
TB Comorbidities and special conditions |
| 3205 |
Overview of TB-HIV Collaborative Activities under NTEP |
07/06/2024 |
TB Comorbidities and special conditions |
| 3206 |
NACP and NTEP Coordination at National, State and District Levels |
07/06/2024 |
TB Comorbidities and special conditions |
| 3207 |
State AIDS Control Society [SACS] |
07/06/2024 |
TB Comorbidities and special conditions |
| 3249 |
Quarterly report on TB-HIV Collaborative Activities |
07/06/2024 |
TB Comorbidities and special conditions |
| 3248 |
Ni-kshay HIV Status Report |
07/06/2024 |
TB Comorbidities and special conditions |
| 3209 |
Linkage to TB-HIV services in the private sector |
07/06/2024 |
TB Comorbidities and special conditions |
| 3250 |
Performance Indicators and Targets for TB-HIV Collaborative Activities |
07/06/2024 |
TB Comorbidities and special conditions |
| 3251 |
TB-HIV joint review mechanisms |
07/06/2024 |
TB Comorbidities and special conditions |
| 3257 |
Treatment of DR-TB with HIV Coinfection |
07/06/2024 |
TB Comorbidities and special conditions |
| 3258 |
Treatment of DS-TB with HIV Coinfection |
07/06/2024 |
TB Comorbidities and special conditions |
| 3260 |
Isoniazid Preventive Therapy [IPT] in People Living with HIV [PLHIV] |
07/06/2024 |
TB Comorbidities and special conditions |
| 3262 |
Prevention of TB in facilities caring for HIV-infected persons |
07/06/2024 |
TB Comorbidities and special conditions |
| 3263 |
Reporting of ICF activities among PLHIV |
07/06/2024 |
TB Comorbidities and special conditions |
| 3279 |
F-ICTC |
07/06/2024 |
TB Comorbidities and special conditions |
| 3281 |
DR TB with HIV Co-infection |
07/06/2024 |
TB Comorbidities and special conditions |
| 4540 |
National Framework for A Gender-Responsive Approach to TB in India |
07/06/2024 |
TB Comorbidities and special conditions |
